Prognostic Significance of Acute Kidney Injury After Reperfused ST-Elevation Myocardial Infarction: Synergistic Acceleration of Renal Dysfunction and Left Ventricular Remodeling

Journal of Cardiac Failure

Volumn 16, Issue 5, 2010, Pages 381-389

  Anzai, Atsushi ^a   Anzai, Toshihisa ^a   Naito, Kotaro ^a   Kaneko, Hidehiro ^a   Mano, Yoshinori ^a   Jo, Yusuke ^a   Nagatomo, Yuji ^a   Maekawa, Yuichiro ^a   Kawamura, Akio ^a   Yoshikawa, Tsutomu ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

heart failure; inflammation; Kidney; oxidative stress

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; NORADRENALIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART DEATH; HEART LEFT VENTRICLE; HEART MUSCLE REPERFUSION; HORMONAL REGULATION; HUMAN; INFLAMMATION; KIDNEY INJURY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CREATININE; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; INCIDENCE; INFLAMMATION; INTERLEUKIN-6; JAPAN; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; OXIDATIVE STRESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77951631707     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.12.020     Document Type: Article

References (43)

1. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Tokmakova M.P., Skali H., Kenchaiah S., Braunwald E., Rouleau J.L., Packer M., et al. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation 110 (2004) 3667-3673
4. Naito K., Anzai T., Yoshikawa T., Anzai A., Kaneko H., Kohno T., et al. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling. J Card Fail 14 (2008) 831-838
5. Bongartz L.G., Cramer M.J., Doevendans P.A., Joles J.A., and Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 26 (2005) 11-17
6. Parikh C.R., Coca S.G., Wang Y., Masoudi F.A., and Krumholz H.M. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 168 (2008) 987-995
7. Newsome B.B., Warnock D.G., McClellan W.M., Herzog C.A., Kiefe C.I., Eggers P.W., et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 168 (2008) 609-616
8. Mehta R.L., Kellum J.A., Shah S.V., Molitoris B.A., Ronco C., Warnock D.G., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11 (2007) R31
9. Rich M.W., and Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 150 (1990) 1237-1242
10. Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1780-1785
11. Choudhury D., and Ahmed Z. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol 2 (2006) 80-91
12. Brady H.R., and Singer G.G. Acute renal failure. Lancet 346 (1995) 1533-1540
13. Thadhani R., Pascual M., and Bonventre J.V. Acute renal failure. N Engl J Med 334 (1996) 1448-1460
14. Schrier R.W., Wang W., Poole B., and Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114 (2004) 5-14
15. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17 (2006) 1503-1520
16. Fujii T., Kurata H., Takaoka M., Muraoka T., Fujisawa Y., Shokoji T., et al. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure. Eur J Pharmacol 481 (2003) 241-248
17. Nath K.A., and Norby S.M. Reactive oxygen species and acute renal failure. Am J Med 109 (2000) 665-678
18. Brewster U.C., and Perazella M.A. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 116 (2004) 263-272
19. Anzai T., Yoshikawa T., Shiraki H., Asakura Y., Akaishi M., Mitamura H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96 (1997) 778-784
20. Takahashi T., Anzai T., Yoshikawa T., Maekawa Y., Asakura Y., Satoh T., et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction-role of neurohormones and cytokines. Int J Cardiol 88 (2003) 257-265
21. Maekawa Y., Anzai T., Yoshikawa T., Asakura Y., Takahashi T., Ishikawa S., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 39 (2002) 241-246
22. Naito K., Anzai T., Yoshikawa T., Maekawa Y., Sugano Y., Kohno T., et al. Increased body temperature after reperfused acute myocardial infarction is associated with adverse left ventricular remodeling. J Card Fail 13 (2007) 25-33
23. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20 (1992) 248-254
24. Flaherty J.D., Udelson J.E., Gheorghiade M., Wu E., and Davidson C.J. Assessment and key targets for therapy in the post-myocardial infarction patient with left ventricular dysfunction. Am J Cardiol 102 (2008) 5G-12G
25. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovascular research 81 (2009) 482-490
26. Killip III T., and Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967) 457-464
27. Forrester J.S., Diamond G., Chatterjee K., and Swan H.J. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med 295 (1976) 1356-1362
28. Chertow G.M., Burdick E., Honour M., Bonventre J.V., and Bates D.W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16 (2005) 3365-3370
29. Goldberg A., Hammerman H., Petcherski S., Zdorovyak A., Yalonetsky S., Kapeliovich M., et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 150 (2005) 330-337
30. Hillege H.L., van Gilst W.H., van Veldhuisen D.J., Navis G., Grobbee D.E., de Graeff P.A., et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 24 (2003) 412-420
31. Eijkelkamp W.B., de Graeff P.A., van Veldhuisen D.J., van Dokkum R.P., Gansevoort R.T., de Jong P.E., et al. Effect of first myocardial ischemic event on renal function. Am J Cardiol 100 (2007) 7-12
32. van Dokkum R.P., Eijkelkamp W.B., Kluppel A.C., Henning R.H., van Goor H., Citgez M., et al. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol 15 (2004) 3103-3110
33. Sadeghi H.M., Stone G.W., Grines C.L., Mehran R., Dixon S.R., Lansky A.J., et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2775
34. Abuelo J.G. Normotensive ischemic acute renal failure. N Engl J Med 357 (2007) 797-805
35. Schor N. Acute renal failure and the sepsis syndrome. Kidney Int 61 (2002) 764-776
36. Schrier R.W., and Wang W. Acute renal failure and sepsis. N Engl J Med 351 (2004) 159-169
37. Nagaya N., Goto Y., Nishikimi T., Uematsu M., Miyao Y., Kobayashi Y., et al. Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction. Clin Sci (Lond) 96 (1999) 129-136
38. Kelly K.J. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 14 (2003) 1549-1558
39. Molitoris B.A., Levin A., Warnock D.G., Joannidis M., Mehta R.L., Kellum J.A., et al. Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol 3 (2007) 439-442
40. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14 (2003) 2534-2543
41. Ichimura T., Bonventre J.V., Bailly V., Wei H., Hession C.A., Cate R.L., et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273 (1998) 4135-4142
42. Parikh C.R., and Devarajan P. New biomarkers of acute kidney injury. Critical care medicine 36 (2008) S159-S165
43. Marenzi G., Assanelli E., Campodonico J., De Metrio M., Lauri G., Marana I., et al. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med 38 (2010) 438-444